Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving leading biopharmaceutical companies globally:

McKesson
Medtronic
Harvard Business School
Merck
Dow
Moodys

Last Updated: December 6, 2019

DrugPatentWatch Database Preview

Litigation Details for RECKITT BENCKISER PHARMACEUTICALS, INC. v. BIODELIVERY SCIENCES INTERNATIONAL, INC. (D.N.J. 2014)

See Plans and Pricing

« Back to Dashboard

RECKITT BENCKISER PHARMACEUTICALS, INC. v. BIODELIVERY SCIENCES INTERNATIONAL, INC. (D.N.J. 2014)

Docket   Start Trial Date Filed 2014-09-22
Court District Court, D. New Jersey Date Terminated 2015-07-21
Cause 35:271 Patent Infringement Assigned To Michael Andre Shipp
Jury Demand Plaintiff Referred To Tonianne J. Bongiovanni
Parties BIODELIVERY SCIENCES INTERNATIONAL, INC.; MONOSOL RX, LLC; QUINTILES COMMERCIAL US, INC.; RECKITT BENCKISER PHARMACEUTICALS, INC.
Patents 8,765,167
Attorneys AURORA CASSIRER; DAVID L. HECHT; MARK I. SCHLESINGER; ROBERT LLOYD GREENFELD; SCOTT S. CHRISTIE
Firms McCarter and English, LLP; Steptoe and Johnson LLP; Troutman Sanders LLP; Troutman Sanders LLP, the Chrysler Building
Link to Docket External link to docket
Small Molecule Drugs cited in RECKITT BENCKISER PHARMACEUTICALS, INC. v. BIODELIVERY SCIENCES INTERNATIONAL, INC.
The small molecule drug covered by the patent cited in this case is   Start Trial .

Details for RECKITT BENCKISER PHARMACEUTICALS, INC. v. BIODELIVERY SCIENCES INTERNATIONAL, INC. (D.N.J. 2014)

Date Filed Document No. Description Snippet Link To Document
2014-09-22 1 action for patent infringement related to United States Patent No. 8,765,167 (“the ’167 patent”), arising… (Infringement as to U.S. Patent No. 8,765,167) 22. Plaintiffs reallege the…THE ASSERTED PATENT 15. Plaintiff MonoSol is the lawful owner of the ’167 patent. The ’167 …’167 patent; D. A judgment finding that Defendants’ infringement of the ’167 patent has …arising under the Patent Laws of the United States, Title 35 of the United States Code. 2. External link to document
2014-12-12 14 Defendants' Memorandum of Law In Support of Their Motion to Dismiss infringed U.S. Patent No. 8,765,167 (the “’167 patent”), a patent closely related to the patents-in-suit in…a declaratory judgment that U.S. Patent No. 8,475,832 – the patent asserted by Plaintiffs in the First…knew of the patent-in-suit, specifically intended that a third party infringe the patent-in-suit, and…aware of the recently-issued ’167 patent, or understood the patent sufficiently to have knowledge that…of the ’167 patent, nor that it had knowledge third parties were infringing that patent. External link to document
2015-07-21 27 infringement of a patent related to Suboxone, U.S. Patent No. 8,765,167 (the “’167 patent”). (Pls.’ Opp’n…making it. (Ia'. il 15; Ex. A-l, U.S. Patent No. 8,765,167, Abstract (filed Sep. 8, 2006), ECF No. …’832 Patent or U.S. Patent No. 7,897,080 (the “’08() Patent”).4 (Ia'. il 7.) The ’080 Patent is owned…alleged that Bunavail infringed U.S. Patent No. 8,4752832 (the “’832 Patent”). (Ic!. iiil 42-5 l .) RBP and…exclusive licensees of the Patent. (Chiistie Decl., Ex. 5 il 9.) The ’832 Patent is entitled “Sublingual External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Moodys
Boehringer Ingelheim
Medtronic
Baxter
Dow
Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.